Remove Cannabinoids Remove Cannabis Remove Data Remove Safety
article thumbnail

Cannabinoids, Influenza, and Coronavirus

Americans for Safe Access

With everything happening in the news lately, we want to present some scientific data to help medical cannabis patients and adult-use consumers make informed decisions in regard to cannabis products available, product safety, and personal health.

article thumbnail

Clinical Trial: Cannabinoid Administration Via a Metered-Dose Inhaler Is Safe and Effective for Chronic Pain Patients

NORML

The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain. Additional information regarding cannabinoids and pain appears online h ere.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

FDA Releases Plan To Obtain Data Regarding Cannabis-Derived Product Usage & Safety

Cannabis Law Report

Earlier this month, the FDA released a seven-page plan to accelerate its research into the safety of cannabis-derived products. Piloting market surveillance tools to monitor unapproved cannabis-derived products and “identify potential safety issues before the issues become mainstream.”

Safety 52
article thumbnail

Report: Efficacy and safety of medical cannabinoids in children: a systematic review and meta-analysis

Cannabis Law Report

Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncertain. The objective was to study the efficacy and safety of medical cannabinoids in children. A qualitative assessment suggests that medical cannabinoids might be associated with adverse mental events.

Safety 52
article thumbnail

NCIA Event, June 13: Paul Coble Moderates Panel on Testing and Labeling for “Minor Cannabinoid” Products

Canna Law Blog

We are pleased to announce Paul Coble as a panelist moderator for the National Cannabis Industry Association (NCIA) webinar event this coming Tuesday, Jun 13, 2023 at 12:00 PM. The event is titled, From Lab to Label: Safegaurding Consumers in the Cannabinoid Product Landscape.

Events 72
article thumbnail

Cannabinoids May Promote a Good Night’s Sleep, Study Finds

Veriheal

This is good news for cannabis consumers since a team of Canadian investigators recently revealed that insomniacs reported improvements in their sleep patterns after cannabis consumption. Treating Insomnia With Cannabinoids. All of the study subjects self-administered cannabis products from the comfort of their own home.

Sleep 98
article thumbnail

Sapphire Medical Clinics present new data from the UK Medical Cannabis Registry at the 31st Annual International Cannabinoid Research Society Symposium on Cannabinoids

Cannabis Law Report

Sapphire Medical Clinics presented six abstracts focused on the latest research on cannabinoids based on data from the UK Medical Cannabis Registry during the 31st Annual International Cannabinoid Research Society Symposium on the Cannabinoids (ICRS2021). PROGRAMME.and.ABSTRACTS. Patient-reported outcomes.